Celgene (http://online.wsj.com/quotes/main.html?type=djn&symbol=CELG)
Corp. said it would price its new medicine for a rare blood disease at about $54,000 annually, and argued that the drug would save the health-care system money.
Um… well, I’m glad I’m going to be in a trial. Free drugs. Even though I have good insurance, there is a lifetime limit of a million dollars. If I live 10 more years on drugs that cost $50 a year, that will use half! Zometa is almost $20k a year, although I doubt I’ll be on that every month for the rest of my life, since it’s known to cause ONJ in some patients. I’m going to see if I can cut back to every other month for now.